Public Citizen Comments for House Regarding Compounding Pharmacy Legislation
July 16, 2013
View as PDF.
View press release
Public Citizen expresses our grave concerns with all three pending pieces of legislation on pharmacy compounding. There may be significant differences between these three proposals, but all of them put patients at risk by permitting compounding pharmacies to engage in drug manufacturing activity without seeking a new drug approval from the Food and Drug Administration (FDA) or complying with important federal drug labeling requirements.